Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Valve Hemodynamic Optimization Based on Doppler-Echocardiography Versus Catheterization Measurements Following Valve-in-Valve TAVR: A Prospective Randomized Trial

NCT05459233 is registered in ClinicalTrials.gov with Institut universitaire de cardiologie et de pneumologie de Québec, University Laval as lead sponsor.

NCT NCT05459233
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05459233 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Valve Hemodynamic Optimization Based on Doppler-Echocardiography Versus Catheterization Measurements Following Valve-in-Valve TAVR: A Prospective Randomized Trial
Lead sponsor
Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
Phase
Not applicable
Overall status
Recruiting
Start date
January 11, 2023
Completion date
September 1, 2029
Enrollment
310 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

aortic valve regurgitation, aortic valve stenosis, prosthesis failure